IRIS
LUZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.803
AS - Asia 3.275
EU - Europa 1.890
SA - Sud America 835
AF - Africa 67
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 9.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.641
SG - Singapore 1.366
CN - Cina 761
IT - Italia 730
BR - Brasile 649
VN - Vietnam 430
IN - India 372
DE - Germania 348
GB - Regno Unito 252
SE - Svezia 153
FI - Finlandia 149
CA - Canada 115
AR - Argentina 78
NL - Olanda 72
IR - Iran 56
BD - Bangladesh 40
HK - Hong Kong 40
EC - Ecuador 34
ID - Indonesia 34
MX - Messico 34
RU - Federazione Russa 32
JP - Giappone 31
TR - Turchia 27
PL - Polonia 23
ES - Italia 21
IQ - Iraq 21
UA - Ucraina 19
ZA - Sudafrica 19
AU - Australia 17
CO - Colombia 17
CL - Cile 16
CZ - Repubblica Ceca 14
FR - Francia 14
IL - Israele 14
TW - Taiwan 14
PK - Pakistan 13
PY - Paraguay 13
MA - Marocco 10
PE - Perù 10
UY - Uruguay 10
UZ - Uzbekistan 10
RO - Romania 9
AT - Austria 8
EG - Egitto 8
IE - Irlanda 7
RS - Serbia 7
EU - Europa 6
VE - Venezuela 6
KE - Kenya 5
OM - Oman 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
PH - Filippine 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BE - Belgio 3
BH - Bahrain 3
CH - Svizzera 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
LT - Lituania 3
MG - Madagascar 3
NG - Nigeria 3
NP - Nepal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AO - Angola 2
CU - Cuba 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 9.892
Salva come PNG Salva come JPEG
Città #
Chandler 533
Singapore 473
Dallas 320
Munich 292
Santa Clara 292
Bengaluru 275
Hefei 274
Milan 243
Chicago 228
Princeton 211
Lawrence 210
London 203
Ho Chi Minh City 171
Ashburn 160
Wilmington 132
Beijing 85
Helsinki 83
Ottawa 82
Hanoi 78
Des Moines 68
São Paulo 65
Turku 48
Los Angeles 47
Boardman 46
Shanghai 38
Rome 35
Catanzaro 33
Naples 31
Hong Kong 30
Guangzhou 29
New York 27
Redwood City 27
Cittanova 22
Hanover 22
Pune 22
Haiphong 21
Mumbai 20
Norwalk 19
San Francisco 18
Da Nang 17
Rio de Janeiro 17
Council Bluffs 16
Phoenix 16
Redmond 16
Brooklyn 15
The Dalles 15
Warsaw 15
Montreal 14
Palermo 14
Tokyo 14
Dhaka 13
Shenzhen 13
Bari 12
Belo Horizonte 12
Brasília 12
Guayaquil 12
Istanbul 12
Mendicino 12
Osaka 12
Stockholm 12
Curitiba 11
Hải Dương 11
Jyväskylä 11
Campinas 10
Chennai 10
Salvador 10
San Nicola Manfredi 10
Thái Nguyên 10
Atlanta 9
Biên Hòa 9
Boston 9
Cosenza 9
Montevideo 9
Olomouc 9
Praia A Mare 9
Tashkent 9
Amsterdam 8
Charlotte 8
Jiaxing 8
Quito 8
Tehran 8
Collegeville 7
Dublin 7
Johannesburg 7
Marília 7
Viamão 7
Ankara 6
Assago 6
Central 6
Horia 6
Jerusalem 6
Lấp Vò 6
Mexico City 6
Phủ Lý 6
Santo André 6
Sorocaba 6
São Gonçalo 6
Vienna 6
Wuhan 6
Buffalo 5
Totale 5.617
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 235
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 190
Dietary polyphenolsand non-alcoholic fatty liver disease 96
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 81
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials 78
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 78
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 76
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 70
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 70
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 68
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 67
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 66
The role of gluten-free diet in nonalcoholic fatty liver disease development 66
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 65
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 65
Applications of Text Mining techniques to extract meaningful information from gastroenterology medical reports 63
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 60
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 60
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 60
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 59
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 59
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 59
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 59
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 59
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 57
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 56
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 56
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 55
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 55
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 55
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 54
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 54
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 54
Ancient wheats: beneficial effects on insulin resistance 54
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 54
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 53
Primary clarithromycin resistance in Helicobacter pylori: The multicentric Italian clarithromycin resistance observational (MICRO) study 53
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 53
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 52
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 52
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 51
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 51
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 50
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 50
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 50
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 50
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 49
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 49
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 48
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 48
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 48
Bioactive IL-18 expression is up-regulated in Crohn's disease 48
Antibacterial drugs in Crohn's disease 48
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 47
Gut microbiota and non-alcoholic fatty liver disease 47
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 46
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 46
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 46
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 46
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 45
La calcolosi della colecisti 45
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 45
Tumeurs benignes et malignes du duodenum 45
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 44
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 44
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 44
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 44
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 44
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 44
Bone mineralization in celiac disease 44
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 44
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 43
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 43
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 43
NON ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH INCREASED CENTRAL BODY FAT BY DUAL-ENERGY X-RAY ABSORPTIOMETRY 43
Circulating D dimer in inflammatory bowel disease 42
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 42
Critical review on the use and abuse of alcohol. When the dose makes the difference. 42
Author correction to Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells [Infect. Immun. 72, 9, (2004) 5019-5026] 42
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 42
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 41
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 41
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 41
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 40
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 40
Serum Adipokine Levels in Overweight Patients With non-alchoolic Fatty Liver Disease 40
Helicobacter pylori-specific IgG in chronic haemodialysis patients: Relationship of hypergastrinaemia to positive serology 40
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 39
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 39
Follow-up clinico-endoscopico in 32 casi di adenoma maligno del colon 39
Interazione Ospite-Batterio 39
Colite ulcerosa: problemi di istopatologia 39
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 38
Gut microbiota changes and chronic hepatitis C virus infection 38
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 38
Low prevalence of p-ANCA in unaffected relatives of patients with ulcerative colitis from a Mediterranean area 38
Trattamento medico della litiasi colesterolica 38
Serum adipokine levels in overweight patients with non-alcolich fatty liver disease. 38
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 38
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 38
Totale 5.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 17 15 26 47 10 4 3
2021/2022568 13 11 16 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.934 386 182 176 67 173 388 192 155 421 90 250 454
2025/20263.350 294 616 641 1.064 595 140 0 0 0 0 0 0
Totale 10.182